Kei Amemiya

2.7k citations

52 papers · 2.2k indexed · 1 hit paper · h-index 23

Oncology top 5%
Epidemiology top 5%
Molecular Biology
Electrical and Electronic Engineering top 10%
Immunology top 10%

Co-authors: Eugene O. Major Sidney A. Houff Joseph R. Berger Carlo Tornatore Renee G. Traub Avindra Nath David M. Waag David DeShazer
Topics: Burkholderia infections and melioidosis (19 papers)Yersinia bacterium, plague, ectoparasites research (9 papers)Polyomavirus and related diseases (7 papers)
Cited by: Virology Oncology Parasitology
Journals: Proceedings of the National Academy of Sciences Journal of Biological Chemistry The Journal of Experimental Medicine
Partner nations: United States Germany Japan

In The Last Decade

Kei Amemiya

52 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pathogenesis and molecular biology of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain

1992 448 citations Eugene O. Major, Kei Amemiya et al. profile →

Peers

Countries citing papers authored by Kei Amemiya

Since Specialization

Citations

This map shows the geographic impact of Kei Amemiya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kei Amemiya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kei Amemiya more than expected).

Fields of papers citing papers by Kei Amemiya

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kei Amemiya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kei Amemiya. The network helps show where Kei Amemiya may publish in the future.

Co-authorship network of co-authors of Kei Amemiya

This figure shows the co-authorship network connecting the top 25 collaborators of Kei Amemiya. A scholar is included among the top collaborators of Kei Amemiya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kei Amemiya. Kei Amemiya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Shiga-Toxin-Producing Strains of Escherichia coli O104:H4 and a Strain of O157:H7, Which Can Cause Human Hemolytic Uremic Syndrome, Differ in Biofilm Formation in the Presence of CO2 and in Their Ability to Grow in a Novel Cell Culture Medium 2023 ·Microorganisms ·Kei Amemiya,David A. Rozak,(unknown),(unknown),C. Marchand,David P. Fetterer,Patricia L. Worsham,B K Purcell	5
2	Comparison of three non-human primate aerosol models for glanders, caused by Burkholderia mallei 2021 ·Microbial Pathogenesis ·David M. Waag,Taylor Chance,(unknown),Franco Rossi,David P. Fetterer,Kei Amemiya,(unknown),Susham S. Ingavale,(unknown),Xiankun Zeng,Steven J. Kern,Patricia L. Worsham,Christopher K. Cote,Susan L. Welkos	6
3	Comparative virulence of three different strains of Burkholderia pseudomallei in an aerosol non-human primate model 2021 ·PLoS neglected tropical diseases ·(unknown),(unknown),David P. Fetterer,Christopher P. Klimko,Jo Lynne Raymond,(unknown),(unknown),David M. Waag,Patricia L. Worsham,Kei Amemiya,(unknown),Christopher K. Cote,Teresa Krakauer	10
4	Characterization of pathogenesis of and immune response to Burkholderia pseudomallei K96243 using both inhalational and intraperitoneal infection models in BALB/c and C57BL/6 mice 2017 ·PLoS ONE ·Jeremy J. Bearss,(unknown),(unknown),(unknown),Christopher P. Klimko,(unknown),Jennifer L. Shoe,(unknown),(unknown),W.M. Webster,David P. Fetterer,Joel A. Bozue,Patricia L. Worsham,Susan L. Welkos,Kei Amemiya,Christopher K. Cote	26
5	Phenotypic Characterization of a Novel Virulence-Factor Deletion Strain of Burkholderia mallei That Provides Partial Protection against Inhalational Glanders in Mice 2016 ·Frontiers in Cellular and Infection Microbiology ·Joel A. Bozue,Sidhartha Chaudhury,Kei Amemiya,Jennifer Chua,Christopher K. Cote,(unknown),(unknown),Christopher P. Klimko,Catherine L. Wilhelmsen,(unknown),Nela Zavaljevski,Jaques Reifman,Anders Wallqvist	12
6	Characterization of in vitro phenotypes of Burkholderia pseudomallei and Burkholderia mallei strains potentially associated with persistent infection in mice 2016 ·Archives of Microbiology ·(unknown),Christopher K. Cote,Kei Amemiya,David M. Waag,Christopher P. Klimko,Patricia L. Worsham,Susan L. Welkos	12
7	Comparison of the early host immune response to two widely diverse virulent strains of Burkholderia pseudomallei that cause acute or chronic infections in BALB/c mice 2015 ·Microbial Pathogenesis ·Kei Amemiya,(unknown),David P. Fetterer,Patricia L. Worsham,Susan L. Welkos,Christopher K. Cote	17
8	A Unique Set of the Burkholderia Collagen-Like Proteins Provides Insight into Pathogenesis, Genome Evolution and Niche Adaptation, and Infection Detection 2015 ·PLoS ONE ·(unknown),Soo Jeon Choi,Annа K. Snyder,Rita V. M. Rio,(unknown),Lisa Holland,Kei Amemiya,Susan L. Welkos,Joel A. Bozue,Christopher K. Cote,Rita Berisio,Sławomir Łukomski	23
9	Characterization of Burkholderia pseudomallei Strains Using a Murine Intraperitoneal Infection Model and In Vitro Macrophage Assays 2015 ·PLoS ONE ·Susan L. Welkos,Christopher P. Klimko,Steven J. Kern,Jeremy J. Bearss,Joel A. Bozue,(unknown),(unknown),David M. Waag,Kei Amemiya,Patricia L. Worsham,Christopher K. Cote	45
10	Characterization of cellular immune response and innate immune signaling in human and nonhuman primate primary mononuclear cells exposed to Burkholderia mallei 2014 ·Microbial Pathogenesis ·Shahabuddin Alam,Kei Amemiya,(unknown),Robert G. Ulrich,David M. Waag,Kamal U. Saikh	10
11	Rapid Countermeasure Discovery against Francisella tularensis Based on a Metabolic Network Reconstruction 2013 ·PLoS ONE ·Sidhartha Chaudhury,Mohamed Diwan M. AbdulHameed,Narender Singh,Gregory J. Tawa,Patrik D’haeseleer,Adam Zemła,Ali Navid,(unknown),Matthew C. Franklin,Jonah Cheung,M. Rudolph,J. Love,John Graf,David A. Rozak,(unknown),Kei Amemiya,Simon Daefler,Anders Wallqvist	13
12	Human Anti-Plague Monoclonal Antibodies Protect Mice from Yersinia pestis in a Bubonic Plague Model 2010 ·PLoS ONE ·Xiaodong Xiao,Zhongyu Zhu,(unknown),(unknown),Randy Fast,Patricia L. Worsham,Christopher K. Cote,Kei Amemiya,Dimiter S. Dimitrov	30
13	CpG oligodeoxynucleotides augment the murine immune response to the Yersinia pestis F1-V vaccine in bubonic and pneumonic models of plague 2009 ·Vaccine ·Kei Amemiya,Jennifer Meyers,(unknown),Randy Fast,(unknown),Patricia L. Worsham,Bradford S. Powell,Sarah L. Norris,Arthur Μ. Krieg,Jeffrey J. Adamovicz	27
14	Detection of the host immune response to Burkholderia mallei heat-shock proteins GroEL and DnaK in a glanders patient and infected mice 2007 ·Diagnostic Microbiology and Infectious Disease ·Kei Amemiya,Jennifer Meyers,David DeShazer,(unknown),(unknown),Marilyn J. England,Wilson J. Ribot,Sarah L. Norris,David M. Waag	20
15	Aerogenic vaccination with a Burkholderia mallei auxotroph protects against aerosol-initiated glanders in mice 2004 ·Vaccine ·Ricky L. Ulrich,Kei Amemiya,David M. Waag,Chad J. Roy,David DeShazer	47
16	Downregulation of TGF-β1 mRNA and Protein in the Muscles of Patients with Inflammatory Myopathies after Treatment with High-Dose Intravenous Immunoglobulin 2000 ·Clinical Immunology ·Kei Amemiya,C. Semino–Mora,(unknown),(unknown)	97
17	Clonal restriction of T-cell receptor expression by infiltrating lymphocytes in inclusion body myositis persists over time: Studies in repeated muscle biopsies 2000 ·Brain ·Kei Amemiya	83
18	Interaction of the human polyomavirus, JCV, with human B-lymphocytes 1992 ·Virology ·Walter J. Atwood,Kei Amemiya,Renee G. Traub,(unknown),Eugene O. Major	97
19	Glial cells of the human developing brain and B cells of the immune system share a common DNA binding factor for recognition of the regulatory sequences of the human polyomavirus, JCV 1990 ·Journal of Neuroscience Research ·Eugene O. Major,Kei Amemiya,Gregory A. Elder,Sidney A. Houff	83
20	Conserved sequence elements upstream and downstream from the transcription initiation site of the Caulobacter crescentus rrnA gene cluster 1989 ·Journal of Molecular Biology ·Kei Amemiya	7

About Kei Amemiya

Kei Amemiya is a scholar working on Parasitology, Pharmacology and Epidemiology, having authored 52 papers that have together received 2.2k indexed citations. Recurring topics across this work include Burkholderia infections and melioidosis (19 papers), Yersinia bacterium, plague, ectoparasites research (9 papers) and Polyomavirus and related diseases (7 papers). The work is most often cited by research in Virology (238 citations), Oncology (815 citations) and Parasitology (116 citations). Kei Amemiya has collaborated with scholars based in United States, Germany and Japan. Frequent co-authors include Eugene O. Major, Sidney A. Houff, Joseph R. Berger, Carlo Tornatore, Renee G. Traub, Avindra Nath, Carlo Tornatore, David M. Waag, David DeShazer and K Wood. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Experimental Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact